Skip to main content
Fig. 6 | Arthritis Research & Therapy

Fig. 6

From: Restrictive IgG antibody response against mutated citrullinated vimentin predicts response to rituximab in patients with rheumatoid arthritis

Fig. 6

Mean IgA anti-MCV titer course for responders and non-responders to RTX corresponding to their achieved Disease Activity Score 28 (DAS28) after RTX treatment. The achieved DAS28 and treatment response at week 24 according to the EULAR response criteria were reflected by the extent of anti-MCV IgA titer reductions. The better the DAS28 responses were, the greater the IgA anti-MCV reductions were. Responders in remission showed the greatest IgA anti-MCV reductions, whereas non-responders with high disease activity slightly increased their initial levels. EULAR, European League against Rheumatism; HDA, high disease activity; LDA, low disease activity; MDA, moderate disease activity

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us